Publications by authors named "Sasha Kravets"

9Publications

Tumor volume dynamics and tumor growth rate in -rearranged advanced non-small-cell lung cancer treated with crizotinib.

Eur J Radiol Open 2020 28;7:100210. Epub 2020 Jan 28.

Department of Medical Oncology and Department of Medicine, Dana-Farber Cancer Institute and Brigham and Women's Hospital, 450 Brookline Ave., Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejro.2019.12.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569410PMC
January 2020

Success of genomic profiling of non-small cell lung cancer biopsies obtained by trans-thoracic percutaneous needle biopsy.

J Surg Oncol 2018 Dec 27;118(7):1170-1177. Epub 2018 Sep 27.

Department of Medical Oncology, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.25241DOI Listing
December 2018

Development and validation of a new MRI simulation technique that can reliably estimate optimal in vivo scanning parameters in a glioblastoma murine model.

PLoS One 2018 23;13(7):e0200611. Epub 2018 Jul 23.

Department of Imaging, Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0200611PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056046PMC
January 2019

Safety of Programmed Death-1 Pathway Inhibitors Among Patients With Non-Small-Cell Lung Cancer and Preexisting Autoimmune Disorders.

J Clin Oncol 2018 07 10;36(19):1905-1912. Epub 2018 May 10.

Giulia C. Leonardi, Sasha Kravets, Suzanne E. Dahlberg, and Mark M. Awad, Dana-Farber Cancer Institute; Justin F. Gainor and Roxana Azimi, Massachusetts General Hospital; Lydia Gedmintas, Brigham and Women's Hospital, Boston, MA; Mehmet Altan, MD Anderson Cancer Center, Houston, TX; Hira Rizvi and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center; Matthew D. Hellmann, Weill Cornell Medical College, and Parker Institute for Cancer Immunotherapy, New York, NY; and Jonathan W. Riess, University of California Davis Comprehensive Cancer Center, Sacramento, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.0305DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553840PMC
July 2018

Interpretation of Results from Under-accruing Studies.

Oncologist 2018 07 8;23(7):755-756. Epub 2018 May 8.

Dana-Farber Cancer Institute, Boston, Massachusetts, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0145DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058329PMC
July 2018

Cytologic-histologic correlation of programmed death-ligand 1 immunohistochemistry in lung carcinomas.

Cancer Cytopathol 2018 04 5;126(4):253-263. Epub 2018 Feb 5.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncy.21973DOI Listing
April 2018